More than what was expected! They had a net income of $203,130 for the Q2. The Q1 had a big net loss number.
“For the six months ended June 30, 2018, the Company increased overall revenue to approximately $10.3 million, a 3% increase over the same period in 2017. Total revenues included approximately $125,000 of fees earned on dispensing prescription medications to patients under 340B programs managed by two non-profit healthcare organizations in Florida. Total billings collected on behalf of and remitted to these organizations was $2.8 million and $1.0 million for the six months ended June 30, 2018 and 2017, respectively.”